← Leaderboards
Ali Khademhosseini
Mayo Clinic Arizona
$21,426,218
Attributed
$37,139,700
Total exposure
24
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,139,700 · 24
By mechanism
R01$26,328,782 · 14
U01$3,540,991 · 1
R21$2,746,949 · 6
UG3$2,134,549 · 1
RL1$1,946,033 · 1
R56$442,396 · 1
Top collaborators
- Rahmi Oklu19 shared
- Nasim Annabi8 shared
- Eben Alsberg6 shared
- Shiladitya Sengupta5 shared
- Shaochen Chen4 shared
- Sidharta Gangadharan4 shared
- Ronglih Liao4 shared
- Nureddin Ashammakhi2 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoEngineeringIn VitroBiocompatible MaterialsBaseTissuesHydrogelsPropertyDesignPreventCellsTechnologyBiologicalTissue EngineeringMechanicsStructureComplexProceduresDevicesOperative Surgical ProceduresAnimal ModelImplantationPerformanceArea
Grant awards (76)
Drug eluting injectable biomaterials for next generation chemoembolization$617,904
R01 · FY2025 · CA
Healing enterocutaneous fistulas using bioengineered biomaterials$511,541
R01 · FY2025 · DK
Drug eluting injectable biomaterials for next generation chemoembolization$587,009
R01 · FY2024 · CA
Healing enterocutaneous fistulas using bioengineered biomaterials$547,832
R01 · FY2024 · DK
Drug eluting injectable biomaterials for next generation chemoembolization$637,881
R01 · FY2023 · CA
Healing enterocutaneous fistulas using bioengineered biomaterials$572,891
R01 · FY2023 · DK
Drug eluting injectable biomaterials for next generation chemoembolization$650,424
R01 · FY2022 · CA
Engineering a naturally derived and highly adhesive surgical sealant$606,741
R01 · FY2022 · EB
Healing enterocutaneous fistulas using bioengineered biomaterials$591,580
R01 · FY2022 · DK
Engineering highly elastic surgical sealants with hemostatic properties$715,061
R01 · FY2021 · HL
Drug eluting injectable biomaterials for next generation chemoembolization$680,198
R01 · FY2021 · CA
Engineering personalized micro-tumor ecosystems$614,945
U01 · FY2021 · CA
Treatment of arterial aneurysms using an injectable biomaterial$607,500
R01 · FY2021 · HL
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$531,057
UG3 · FY2021 · TR
Engineering personalized micro-tumor ecosystems$742,092
U01 · FY2020 · CA
Engineering highly elastic surgical sealants with hemostatic properties$725,172
R01 · FY2020 · HL
Treatment of arterial aneurysms using an injectable biomaterial$636,694
R01 · FY2020 · HL
Engineering a naturally derived and highly adhesive surgical sealant$629,522
R01 · FY2020 · EB
Targeted chemotherapy delivery and capture$538,425
R01 · FY2020 · EB
High-Throughput Microenvironment Regulation for Chondrogenesis$408,254
R01 · FY2020 · AR
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal and the negative affective component of pain: a therapeutic screening tool.$1,603,492
UG3 · FY2019 · TR
Engineering personalized micro-tumor ecosystems$775,492
U01 · FY2019 · CA
Engineering highly elastic surgical sealants with hemostatic properties$738,089
R01 · FY2019 · HL
Treatment of arterial aneurysms using an injectable biomaterial$683,811
R01 · FY2019 · HL
Engineering a naturally derived and highly adhesive surgical sealant$637,397
R01 · FY2019 · EB
Targeted chemotherapy delivery and capture$541,013
R01 · FY2019 · EB
3D printed muscle-bone organ implant for treating large injuries$433,024
R01 · FY2019 · AR · contact PI
Engineering personalized micro-tumor ecosystems$754,767
U01 · FY2018 · CA
Treatment of arterial aneurysms using an injectable biomaterial$701,500
R01 · FY2018 · HL
Engineering highly elastic surgical sealants with hemostatic properties$627,248
R01 · FY2018 · HL
Targeted chemotherapy delivery and capture$538,020
R01 · FY2018 · EB
3D printed muscle-bone organ implant for treating large injuries$453,761
R01 · FY2018 · AR · contact PI
Rapid 3D bioprinting of biomimetic vascularized tissue constructs$430,864
R01 · FY2018 · EB
Multifunctional dressing for treatment of diabetic wounds$314,214
R01 · FY2018 · GM
Cardiotoxicity Assays on an Integrated Platform of a Heart-on-a-Chip and an Optical Immunosensor$310,273
R01 · FY2018 · GM · contact PI
High-Throughput Microenvironment Regulation for Chondrogenesis$273,044
R01 · FY2018 · AR
High-Throughput Microenvironment Regulation for Chondrogenesis$135,308
R01 · FY2018 · AR
Rapid 3D bioprinting of biomimetic vascularized tissue constructs$120,917
R01 · FY2018 · EB
Engineering personalized micro-tumor ecosystems$653,695
U01 · FY2017 · CA
Targeted chemotherapy delivery and capture$552,870
R01 · FY2017 · EB
Engineering a naturally derived and highly adhesive surgical sealant$540,633
R01 · FY2017 · EB
Rapid 3D bioprinting of biomimetic vascularized tissue constructs$439,172
R01 · FY2017 · EB
High-Throughput Microenvironment Regulation for Chondrogenesis$406,560
R01 · FY2017 · AR
Catheter guided endovascular electric field ablation for thrombosis therapy.$254,750
R21 · FY2017 · EB
Whitlockite nanoparticles for inducing bone regeneration$227,316
R21 · FY2017 · AR · contact PI
Smart wound dressing for treating chronic diabetic ulcers$218,155
R21 · FY2017 · EB · contact PI
Rapid 3D bioprinting of biomimetic vascularized tissue constructs$480,258
R01 · FY2016 · EB
High-Throughput Microenvironment Regulation for Chondrogenesis$406,560
R01 · FY2016 · AR
Smart wound dressing for treating chronic diabetic ulcers$266,250
R21 · FY2016 · EB · contact PI
Catheter guided endovascular electric field ablation for thrombosis therapy.$229,750
R21 · FY2016 · EB
Angiogenic Biomaterials as Dermal Scaffolds to Enhance Diabetic Wound Healing$217,378
R21 · FY2016 · AR · contact PI
Whitlockite nanoparticles for inducing bone regeneration$195,250
R21 · FY2016 · AR · contact PI
High-Throughput Microenvironment Regulation for Chondrogenesis$421,034
R01 · FY2015 · AR
Angiogenic Biomaterials as Dermal Scaffolds to Enhance Diabetic Wound Healing$194,700
R21 · FY2015 · AR · contact PI
A miniaturized model of human skin and lymph node for drug discovery and testing$442,396
R56 · FY2014 · AI · contact PI
3D combinatorial microenvironments for effective cell based therapy$678,553
R01 · FY2013 · HL
3D combinatorial microenvironments for effective cell based therapy$678,207
R01 · FY2012 · HL
Microfabricated Vascularized 3D Tissue Engineered Constructs$431,498
R01 · FY2012 · HL · contact PI
3D combinatorial microenvironments for effective cell based therapy$631,399
R01 · FY2011 · HL
Microfabricated Vascularized 3D Tissue Engineered Constructs$534,906
R01 · FY2011 · HL · contact PI
Microengineered environments for epithelial-mesenchymal interactions (SysCODE 7$381,670
RL1 · FY2011 · DE · contact PI
3D combinatorial microenvironments for effective cell based therapy$637,776
R01 · FY2010 · HL
Microfabricated Vascularized 3D Tissue Engineered Constructs$534,786
R01 · FY2010 · HL · contact PI
MICROFLUIDIC SYSTEM FOR SCREENING STEM CELL MICROENVIRONMENTS$400,400
R01 · FY2010 · EB · contact PI
Microengineered environments for epithelial-mesenchymal interactions (SysCODE 7$385,525
RL1 · FY2010 · DE · contact PI
High-Throughput Analysis of Cell Response to Chemical Libraries$220,275
R21 · FY2010 · EB · contact PI
Microfabricated Vascularized 3D Tissue Engineered Constructs$436,904
R01 · FY2009 · HL · contact PI
MICROFLUIDIC SYSTEM FOR SCREENING STEM CELL MICROENVIRONMENTS$419,650
R01 · FY2009 · EB · contact PI
Microengineered environments for epithelial-mesenchymal interactions (SysCODE 7$389,419
RL1 · FY2009 · DE · contact PI
High-Throughput Analysis of Cell Response to Chemical Libraries$265,000
R21 · FY2009 · EB · contact PI
Microfabricated Vascularized 3D Tissue Engineered Constructs$65,083
R01 · FY2009 · HL · contact PI
Microfabricated Vascularized 3D Tissue Engineered Constructs$429,421
R01 · FY2008 · HL · contact PI
Microengineered environments for epithelial-mesenchymal interactions (SysCODE 7$389,419
RL1 · FY2008 · DE · contact PI
ENGINEERING OF THE MURINE EMBRYONIC STEM CELL MICROENVIRONMENT$214,375
R21 · FY2008 · EB · contact PI
Microengineered environments for epithelial-mesenchymal interactions (SysCODE 7$400,000
RL1 · FY2007 · DE · contact PI
ENGINEERING OF THE MURINE EMBRYONIC STEM CELL MICROENVIRONMENT$243,750
R21 · FY2007 · EB · contact PI